MiNK Therapeutics (INKT) Payables (2020 - 2026)
MiNK Therapeutics (INKT) reported Payables of $3.92 million for Q2 2026, down 55.6% from $8.82 million a year earlier but up 15.5% from the prior quarter.
Powered by 
Analysis
MiNK Therapeutics (INKT) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, MiNK Therapeutics posted Payables of $8.6 million, up 215.4% from FY2024.
- Payables has a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- By year, Payables came in at $2.73 million in FY2024 (-30.3%), $3.91 million in FY2023 (-32.8%), $5.82 million in FY2022 (+94.4%) and $3 million in FY2021 (-4.7%).
- Five-year quarterly Payables spans a low of $2.36 million in Q3 2024 and a high of $67.07 million in Q3 2021.
- Year over year, Payables gained in four of the last eight quarters, with growth averaging 78.2%.
- The high point for year-over-year Payables in five years was Q3 2025 (growth of 298.9%); the low point was Q3 2022 (a decline of 92.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.39 million (Q1 2026), $8.6 million (Q4 2025) and $9.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 7.03 Bn |
| 10 | MiNK Therapeutics | 56.61 Mn | 15.42 Mn | - | 3.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 8.60 Mn |
| Sep 30, 2025 | 9.42 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 4.89 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | 5.82 Mn |
| Sep 30, 2022 | 5.17 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 67.07 Mn |
API Access
MiNK Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=INKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "INKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=INKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();